Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.3K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.3K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Twenty-five years of human metapneumovirus research.

Clinical microbiology reviews·2026
Same author

Use of ANCHOR viruses to validate radiative, physical and chemical decontamination systems in operational conditions.

The Journal of hospital infection·2026
Same author

Respiratory syncytial virus (RSV) and influenza A virus (IAV) interplay with the type I and III interferon (IFN) responses in the respiratory epithelium.

Current opinion in virology·2026
Same author

Landscape of Prophylactic Strategies Against Human Parainfluenza Virus Type 3.

Reviews in medical virology·2025
Same author

Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor.

NPJ vaccines·2025
Same author

Vaccine Development for Human Pneumoviruses.

Vaccines·2025

相关实验视频

Updated: Sep 13, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

调和多个基于连接的系统生物学方法用于药物重定位.

Catalina Gonzalez Gomez1,2,3, Manuel Rosa-Calatrava1,2,3,4, Julien Fouret1,2,3

  • 1CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, 8 rue Guillaume Paradin Faculté de Médecine RTH Laennec, Lyon 69008, France.

Briefings in bioinformatics
|July 30, 2025
PubMed
概括

本综述通过将它们分为两个主要类别来协调各种in silico药物重用方法. 它阐明了这些计算方法的常见结构和具体策略.

关键词:
连接性得分 连接性得分数据集成数据集成数据集成不同的表达方式签名药物重用是为了改变药物的用途.系统生物学 系统生物学

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K

相关实验视频

Last Updated: Sep 13, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K

科学领域:

  • 计算生物学是一种计算生物学.
  • 药理学 药理学是指药理学的学科.
  • 生物信息学是一种生物信息学.

背景情况:

  • 在过去的二十年中,许多用于药物重新定位的in silico方法已经出现,以加速早期药物开发.
  • 数据驱动的方法,特别是那些比较差异化转录组签名的方法,被广泛使用.
  • 系统生物学数据库和网络生物学算法的集成是一个不断增长的趋势.

研究的目的:

  • 调和和澄清各种综合性in silico药物再利用方法的共同结构和具体策略.
  • 为了解决类似的计算方法的不一致的制定.
  • 为理解这些方法提供一个统一的框架.

主要方法:

  • 将整合方法分为两个主要类别.
  • 阐明共同的基础结构和具体的战略差异.
  • 开发每个方法类别的图表化工作流表达.
  • 对分析方法的均质化配方的介绍.

主要成果:

  • 确定两种主要类型的整合性在体中药物重定向方法.
  • 方法工作流程的详细图形表示.
  • 一个统一的配方,简化了对各种计算策略的理解.
  • 阐明各种方法之间的相似之处和差异.

结论:

  • 该综述提供了整合性在中药物重定向方法的结构化概述.
  • 了解共同点和差异有助于更一致的应用和新工具的开发.
  • 这项工作旨在协调该领域并提高药物发现的效率.